Viewing Study NCT04313660


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 4:47 AM
Study NCT ID: NCT04313660
Status: UNKNOWN
Last Update Posted: 2020-03-18
First Post: 2020-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
Sponsor: Xiaorong Dong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module